跳转至内容
Merck
CN

SML0327

Sigma-Aldrich

AM630

≥90% (HPLC)

别名:

6-Iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone, AM 630, Iodopravadoline

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C23H25IN2O3
分子量:
504.36
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

质量水平

检测方案

≥90% (HPLC)

形式

powder

储存条件

desiccated

颜色

white to beige

溶解性

DMSO: >5 mg/mL

储存温度

2-8°C

SMILES字符串

COc1ccc(cc1)C(=O)c2c(C)n(CCN3CCOCC3)c4cc(I)ccc24

InChI

1S/C23H25IN2O3/c1-16-22(23(27)17-3-6-19(28-2)7-4-17)20-8-5-18(24)15-21(20)26(16)10-9-25-11-13-29-14-12-25/h3-8,15H,9-14H2,1-2H3

InChI key

JHOTYHDSLIUKCJ-UHFFFAOYSA-N

应用

AM630 已被用于:
  • 作为大麻素2(CB2)抑制剂用于研究变色栓菌多糖肽 (TPSP) 的镇痛作用。
  • 作为CB2拮抗剂与β-石竹烯(BCP)一起用于研究其对成纤维细胞再上皮化的作用。
  • 作为CB2拮抗剂用于研究其与原代人成骨细胞中的17-β-雌二醇的相互作用。

生化/生理作用

AM630 是一种选择性 CB2 大麻素拮抗剂/反向激动剂(Ki = 31.2 nM),选择性比CB1 受体大150倍。
AM630是一种氨基烷基吲哚,可作为CP 55,940和WIN 55,212-2的竞争性拮抗剂。它也可作为大麻素和(R)-(+)-花生四烯基-1′-羟基-2′-丙酰胺(AM356)的竞争性拮抗剂。

特点和优势

《受体分类和信号转导手册》的 大麻素受体页有该化合物的介绍。想要浏览手册的其他页面, 请单击此处

象形图

Environment

警示用语:

Warning

危险声明

预防措施声明

危险分类

Aquatic Acute 1 - Aquatic Chronic 1

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

R Pertwee et al.
Life sciences, 56(23-24), 1949-1955 (1995-01-01)
AM630 (iodopravadoline), a novel aminoalkylindole, has been found to attenuate the ability of a number of cannabinoids to inhibit electrically-evoked twitches of the mouse isolated vas deferens. It did not block the inhibitory effects of morphine or clonidine on the
Marko Hojnik et al.
Biomedical reports, 3(4), 554-558 (2015-07-15)
The bone remodeling process is influenced by various factors, including estrogens and transmitters of the endocannabinoid system. In osteoblasts, cannabinoid receptors 2 (CB-2) are expressed at a much higher level compared to CB-1 receptors. Previous studies have shown that estrogens
K A Jenkin et al.
British journal of pharmacology, 173(7), 1128-1142 (2014-12-30)
In diabetic nephropathy agonism of CB2 receptors reduces albuminuria and podocyte loss; however, the role of CB2 receptors in obesity-related nephropathy is unknown. The aim of this study was to determine the role of CB2 receptors in a model of
Sachiko Koyama et al.
PloS one, 14(12), e0216104-e0216104 (2019-12-17)
Beta-caryophyllene is an odoriferous bicyclic sesquiterpene found in various herbs and spices. Recently, it was found that beta-caryophyllene is a ligand of the cannabinoid receptor 2 (CB2). Activation of CB2 will decrease pain, a major signal for inflammatory responses. We
Massimo Nabissi et al.
Oncotarget, 7(47), 77543-77557 (2016-10-22)
Several studies showed a potential anti-tumor role for cannabinoids, by modulating cell signaling pathways involved in cancer cell proliferation, chemo-resistance and migration. Cannabidiol (CBD) was previously noted in multiple myeloma (MM), both alone and in synergy with the proteasome inhibitor

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门